Efficacy and Safety of Albumin Paclitaxel Combined With Cisplatin Chemoradiotherapy for Non-resectable Stage III NSCLC
Clinical trial NCT04284215 · UNKNOWN
Trial details
- NCT number
- NCT04284215
- Sponsor
- Guizhou Medical University
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-01
- Primary completion
- 2021-09-30
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.